Skip to main content
. 2024 Oct 23;10(4):e004727. doi: 10.1136/rmdopen-2024-004727

Figure 2. Upper graph summarises the main diagnostics and the therapy administered for DLBCL. The lower left graph shows the circulating CAR-T cell numbers following CAR-T administration. The right middle graph shows representative flow cytometric analysis results of circulating CD-markered cell numbers. The right lower graph shows the IgG levels. CAR-T: chimeric antigen receptor T cell; DLBCL: diffuse large B cell lymphoma; PET: positron emission tomography; R-CNOP: rituximab, cyclophosphamide, mitoxantrone, vincristine and prednisolone.

Figure 2